Charlotte T. Hansen

1.3k total citations · 1 hit paper
41 papers, 963 citations indexed

About

Charlotte T. Hansen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Charlotte T. Hansen has authored 41 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 7 papers in Physiology. Recurrent topics in Charlotte T. Hansen's work include Diabetes Treatment and Management (18 papers), Diabetes Management and Research (15 papers) and Alzheimer's disease research and treatments (5 papers). Charlotte T. Hansen is often cited by papers focused on Diabetes Treatment and Management (18 papers), Diabetes Management and Research (15 papers) and Alzheimer's disease research and treatments (5 papers). Charlotte T. Hansen collaborates with scholars based in Denmark, United States and United Kingdom. Charlotte T. Hansen's co-authors include Henrik Kehlet, Troels S. Jensen, Birgitte Brandsborg, Lone Nikolajsen, Charlotte Møller, Bent Ottesen, Thor Schütt Svane Nielsen, Mark Warren, Lina Steinrud Mørch and Wendy Lane and has published in prestigious journals such as JAMA, Blood and Neurology.

In The Last Decade

Charlotte T. Hansen

37 papers receiving 916 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers

2022 134 citations Charlotte T. Hansen, Lotte Bjerre Knudsen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charlotte T. Hansen Denmark	15	495	437	145	138	104	41	963
T Sane Finland	21	569 1.1×	321 0.7×	336 2.3×	84 0.6×	160 1.5×	34	1.2k
Per‐Eric Lins Sweden	21	874 1.8×	405 0.9×	194 1.3×	237 1.7×	149 1.4×	45	1.3k
Filippo Leonardo Italy	15	525 1.1×	242 0.6×	69 0.5×	228 1.7×	466 4.5×	37	1.1k
Udaya M. Kabadi United States	19	789 1.6×	174 0.4×	219 1.5×	149 1.1×	87 0.8×	112	1.2k
Neil Manowitz United States	8	1.8k 3.7×	199 0.5×	90 0.6×	140 1.0×	114 1.1×	10	2.2k
Elena Cerquetani Italy	13	420 0.8×	115 0.3×	72 0.5×	132 1.0×	311 3.0×	29	941
N Nigro Switzerland	18	237 0.5×	291 0.7×	88 0.6×	58 0.4×	62 0.6×	49	1.1k
MaryAnn Banerji United States	12	795 1.6×	266 0.6×	284 2.0×	75 0.5×	311 3.0×	16	1.4k
Steve Ball France	8	268 0.5×	501 1.1×	147 1.0×	14 0.1×	89 0.9×	8	1.7k
J. L. Touber Netherlands	18	743 1.5×	356 0.8×	105 0.7×	96 0.7×	72 0.7×	31	1.1k

Countries citing papers authored by Charlotte T. Hansen

Since Specialization

Citations

This map shows the geographic impact of Charlotte T. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte T. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte T. Hansen more than expected).

Fields of papers citing papers by Charlotte T. Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte T. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte T. Hansen. The network helps show where Charlotte T. Hansen may publish in the future.

Co-authorship network of co-authors of Charlotte T. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte T. Hansen. A scholar is included among the top collaborators of Charlotte T. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte T. Hansen. Charlotte T. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thorsen, Jonathan, et al.. (2025). Real-world use, safety, and efficacy of teclistamab with or without prophylactic tocilizumab in relapsed/refractory multiple myeloma; Results from the danish ABCD study.. Blood. 146(Supplement 1). 718–718.

Sano, Mary, Jeffrey L. Cummings, Howard Feldman, et al.. (2024). Reasons for screening failure in the evoke and evoke+ trials of semaglutide for early AD. Alzheimer s & Dementia. 20(S6).

Ludwig, Mette Q., Anna Secher, Anne-Mette Bjerregaard, et al.. (2023). A Lipopolysaccharide Mouse Model Mirrors Neuroinflammatory Transcriptional Signatures of Human AD, and the Glucagon-Like Peptide-1 Receptor Agonist Semaglutide Attenuates Neuroinflammation in this Model (P1-6.007). Neurology. 100(17_supplement_2). 1 indexed citations

Cummings, Jeffrey L., Henrik Zetterberg, Alireza Atri, et al.. (2022). Investigating changes in fluid biomarkers in early Alzheimer’s disease: design of plasma biomarker analyses and a cerebrospinal fluid sub‐study in the evoke and evoke+ trials of semaglutide versus placebo. Alzheimer s & Dementia. 18(S5). 1 indexed citations

Thorsen, Jonathan, Charlotte T. Hansen, Mikael Frederiksen, et al.. (2020). Clinically‐suspected cast nephropathy: A retrospective, national, real‐world study. American Journal of Hematology. 95(11). 1352–1360. 10 indexed citations

Heller, Simon, J. Hans DeVries, Carol Wysham, et al.. (2019). Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2. Diabetes Obesity and Metabolism. 21(7). 1634–1641. 11 indexed citations

Salois, Matthew, et al.. (2018). 2018 AVMA report on the market for veterinary services. Digital Collections of Colorado (Colorado State University). 5 indexed citations

Pratley, Richard E., Scott S. Emerson, Edward Franek, et al.. (2018). Cardiovascular (CV) Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (=65 Years) with Type 2 Diabetes (T2D)—Observations from DEVOTE. Diabetes. 67(Supplement_1). 1 indexed citations

Heller, Simon, J. Hans DeVries, Carol Wysham, et al.. (2018). Insulin Degludec Has Lower Hypoglycemia Risk than Insulin Glargine U100 in Older People with Type 2 Diabetes (T2D). Diabetes. 67(Supplement_1). 3 indexed citations

10.

Dicks, Michael R., et al.. (2017). 2017 AVMA report on the market for veterinary services. Digital Collections of Colorado (Colorado State University). 8 indexed citations

11.

Warren, Mark, Louis Chaykin, Serge Jabbour, et al.. (2017). Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin. Clinical Diabetes. 35(2). 90–95. 14 indexed citations

12.

Pan, Changyu, Jorge Luiz Gross, Wenying Yang, et al.. (2016). A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus. Drugs in R&D. 16(2). 239–249. 33 indexed citations

13.

Rasmussen, Kjeld Leisgård, et al.. (2011). Transfusion rate and prevalence of unexpected red blood cell alloantibodies in women undergoing hysterectomy for benign disease. Acta Obstetricia Et Gynecologica Scandinavica. 90(6). 636–641. 4 indexed citations

14.

Kahaly, George J., Charlotte T. Hansen, Edgar A. Otto, et al.. (2009). Diabetic microangiopathy and urinary glycosaminoglycans. Experimental and Clinical Endocrinology & Diabetes. 105(3). 145–151. 7 indexed citations

15.

Hansen, Charlotte T., et al.. (2008). Establishment of a National Danish Hysterectomy Database: Preliminary Report on the First 13,425 Hysterectomies. Obstetrical & Gynecological Survey. 63(9). 567–568. 1 indexed citations

16.

Hansen, Charlotte T., et al.. (2008). Establishment of a national Danish hysterectomy database: Preliminary report on the first 13,425 hysterectomies. Acta Obstetricia Et Gynecologica Scandinavica. 87(5). 546–557. 40 indexed citations

17.

Hansen, Charlotte T., et al.. (2008). Timing of heparin prophylaxis and bleeding complications in hysterectomy a nationwide prospective cohort study of 9,949 Danish women. Acta Obstetricia Et Gynecologica Scandinavica. 87(10). 1039–1047. 17 indexed citations

18.

Hansen, Charlotte T., M. B. Sorensen, Charlotte Møller, Bent Ottesen, & Henrik Kehlet. (2007). Effect of laxatives on gastrointestinal functional recovery in fast-track hysterectomy: a double-blind, placebo-controlled randomized study. American Journal of Obstetrics and Gynecology. 196(4). 311.e1–311.e7. 52 indexed citations

19.

Brandsborg, Birgitte, Lone Nikolajsen, Charlotte T. Hansen, Henrik Kehlet, & Troels S. Jensen. (2007). Risk Factors for Chronic Pain after Hysterectomy. Anesthesiology. 106(5). 1003–1012. 173 indexed citations

20.

Stamenova, P., Rossen Koytchev, Karsten Kuhn, et al.. (2005). A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke. European Journal of Neurology. 12(6). 453–461. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact